Moreover, we determined that SRSF1, by modulating the pro-proliferative Kras 4B isoform, alters cancer stem cell plasticity, the invasive potential of advanced tumours and the viability of primary CRC organoids derived from patients. Here, SRSF1 is linked to neoplasm.